Italy In Vitro Diagnostics Market Size, Growth, Trends | Report 2023-2032
The Italy in vitro diagnostics market size was estimated at around USD 4.41 billion in 2022 and it is projected to hit around USD 3.65 billion by 2032, growing at a CAGR of -1.90% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 4.41 billion |
| Revenue Forecast by 2032 | USD 3.65 billion |
| Growth rate from 2023 to 2032 | CAGR of -1.90% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Companies Covered | F. Hoffmann-La Roche Ltd; Abbott; bioMerieux SA; Danaher; QIAGEN, BD; Sysmex Corporation; DiaSorin S.p.A.; The Menarini Group; SENTINEL CH. SpA; Quidel Corporation |
The exponential decline in demand for IVD products for the detection of COVID-19 infection in the coming years is likely to impede the market’s growth. Whereas the rising prevalence of chronic diseases in the country and the surge in investments by leading players in R&D to develop cutting-edge technologies for exploring new ways to detect diseases are also expected to fuel growth. For instance, in April 2021, Italian test maker DiaSorin put down about USD 1.8 billion for molecular test manufacturer Luminex.
The prevalence of various diseases such as cancer, autoimmune diseases, myocardial infarctions, arrhythmia, and inflammatory conditions is increasing in Italy, which is expected to drive the demand for IVD testing. For instance, according to Globocan, in 2020, about 415,269 new cancer cases and around 174,759 were reported in Italy. Breast cancer, prostate cancer, colorectal cancer, lung, and bladder cancer are some of the most common cancers diagnosed in Italy. Similarly, according to the International Diabetes Federation, in 2022, there were around 4.4 million diabetes cases in the adult population in the country. Unhealthy dietary habits, high tobacco & alcohol consumption, obesity, and a sedentary lifestyle are likely to augment the prevalence of target diseases in the country.
The changes in regulatory policies are expected to fuel IVD market growth in the coming years. For instance, in September 2022, the Government of Italy revised its national regulatory framework regarding IVD products in the country. The change in policies is expected to ensure a higher level of safety of IVD products in the country. Moreover, in September 2021, governments of France and Italy tied up for the distribution of the LoopDeeLab device, based on the RT Lamp molecular biology techniques, in Italy. This device can detect COVID-19 infection in a span of 45 minutes. Such innovative developments promise robust growth for the Italy in vitro diagnostics market during the forecast period.
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Italy In Vitro Diagnostics Market
5.1. COVID-19 Landscape: Italy In Vitro Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Italy In Vitro Diagnostics Market, By Product
8.1. Italy In Vitro Diagnostics Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Italy In Vitro Diagnostics Market, By Technology
9.1. Italy In Vitro Diagnostics Market, by Technology, 2023-2032
9.1.1. Immunoassay
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Hematology
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Clinical Chemistry
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Molecular Diagnostics/Genetics
9.1.4.1. Market Revenue and Forecast (2019-2032)
9.1.5. Coagulation
9.1.5.1. Market Revenue and Forecast (2019-2032)
9.1.6. Microbiology
9.1.6.1. Market Revenue and Forecast (2019-2032)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Italy In Vitro Diagnostics Market, By Application
10.1. Italy In Vitro Diagnostics Market, by Application, 2023-2032
10.1.1. Infectious Disease
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Diabetes
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Oncology/Cancer
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Cardiology
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Nephrology
10.1.5.1. Market Revenue and Forecast (2019-2032)
10.1.6. Autoimmune Diseases
10.1.6.1. Market Revenue and Forecast (2019-2032)
10.1.7. Drug Testing
10.1.7.1. Market Revenue and Forecast (2019-2032)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Italy In Vitro Diagnostics Market, By End-Use
11.1. Italy In Vitro Diagnostics Market, by End-Use, 2023-2032
11.1.1. Core Lab
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Molecular Lab
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Pathology Lab
11.1.3.1. Market Revenue and Forecast (2019-2032)
11.1.4. Blood Banks
11.1.4.1. Market Revenue and Forecast (2019-2032)
11.1.5. Point of Care (PoC)
11.1.5.1. Market Revenue and Forecast (2019-2032)
11.1.6. Retail
11.1.6.1. Market Revenue and Forecast (2019-2032)
11.1.7. Others
11.1.7.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Italy In Vitro Diagnostics Market, Regional Estimates and Trend Forecast
12.1. Italy
12.1.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.2. Market Revenue and Forecast, by Technology (2019-2032)
12.1.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.4. Market Revenue and Forecast, by End-Use (2019-2032)
Chapter 13. Company Profiles
13.1. F. Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abbott
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. bioMerieux SA
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Danaher
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. QIAGEN, BD
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sysmex Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. DiaSorin S.p.A.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. The Menarini Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. SENTINEL CH. SpA
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Quidel Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers